癌细胞在西斯普拉丁化疗中幸存下来,会增加压力诱导的OMA1活性和线粒体分裂
Melvin Li1,2, Chenille A McCullum3, Louis T A Rolle3
1Cancer Ecology Center, The James Brady Urological Institute, Johns Hopkins School of Medicine, Baltimore, MD, 21287, USA. mli154@jh.edu.
Scientific reports
|January 6, 2026
概括
癌细胞通过改变线粒体,对化疗产生抵抗力. 这项研究表明,增加的OMA1活性和减少的线粒体融合有助于耐药细胞在氧化压力下存活,从而提供了新的治疗点.
科学领域:
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
- 线粒体生物学 线粒体生物学
背景情况:
- 癌症治疗耐药性是患者死亡的主要原因之一.
- 线粒体在细胞应激反应和适应中起着至关重要的作用.
- 耐化疗癌细胞可以进入一个大,非增殖状态.
研究的目的:
- 为了研究线粒体在化疗耐药性中的作用.
- 了解癌细胞在治疗中生存的机制.
- 为了确定克服癌症耐药性的潜在治疗点.
主要方法:
- 研究了癌细胞中西斯普拉丁诱导的化疗耐药性.
- 分析了线粒体形态和功能的变化.
- 测量了OMA1活动和线粒体融合动态.
主要成果:
- 进入抗性状态的癌细胞显示OMA1活性增加.
- 线粒体融合和功能在耐药细胞中下降.
- 这些变化与对抗氧化应激有关.
结论:
- 线粒体应激反应是癌症治疗耐药性的关键.
- 在耐药癌细胞中,OMA1活性和线粒体动力学至关重要.
- 针对这些线粒体机制可以克服化疗耐药性.
相关概念视频
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Adaptive Mechanisms in Cancer Cells
6.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.9K
DNA Damage can Stall the Cell Cycle
10.0K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
10.0K
DNA Damage Can Stall the Cell Cycle
3.0K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
3.0K
Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
Cancer Stem Cells and Tumor Maintenance
5.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.9K


